1. Home
  2. OPLN vs IMNM Comparison

OPLN vs IMNM Comparison

Compare OPLN & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OPENLANE Inc.

OPLN

OPENLANE Inc.

N/A

Current Price

$29.66

Market Cap

3.2B

Sector

N/A

ML Signal

N/A

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$21.77

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPLN
IMNM
Founded
2006
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
OPLN
IMNM
Price
$29.66
$21.77
Analyst Decision
Buy
Strong Buy
Analyst Count
4
10
Target Price
$32.00
$32.80
AVG Volume (30 Days)
807.6K
1.2M
Earning Date
04-29-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
51.40
EPS
N/A
N/A
Revenue
N/A
$6,941,000.00
Revenue This Year
$8.66
N/A
Revenue Next Year
$6.14
$1,127.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.81
$6.97
52 Week High
$31.78
$27.65

Technical Indicators

Market Signals
Indicator
OPLN
IMNM
Relative Strength Index (RSI) 62.12 52.34
Support Level $29.48 $19.23
Resistance Level $31.55 $22.86
Average True Range (ATR) 0.71 1.13
MACD 0.29 0.23
Stochastic Oscillator 77.75 64.57

Price Performance

Historical Comparison
OPLN
IMNM

About OPLN OPENLANE Inc.

Openlane Inc provides a digital marketplace for used vehicles, connecting sellers and buyers in North America and Europe for fast and transparent transactions. Its services include financing, repossessions, repairs, transportation, warranty, and inventory management. The company operates used-vehicle auctions and has two main segments: Marketplace and Finance, with majority revenue coming from the Marketplace segment, which to used vehicle remarketing, including marketplace services, remarketing, or make ready services and all are interrelated, synergistic elements along the auto remarketing chain. The Finance segment, through AFC engaged in business of providing short-term, inventory-secured financing to independent vehicle dealers.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: